Multiple Sclerosis Fast Facts

Nov 23, 2020 | health and medicine, Karger Publishers

In Collaboration With

Original Article Reference

This SciPod is a shortened and simplified summary of ‘Fast Facts: Multiple Sclerosis’ published by Karger Publishers: ISBN 978-1-910797-23-5

The complete original works are available at www.karger.com

Short on time? watch this 3 minute video

About this episode

Multiple sclerosis (MS) is a progressive disease of the nervous system resulting from the inflammation and degeneration of nerves. In developed countries, MS is the primary cause of neurological disability in young and middle-aged people. Worldwide, MS affects an estimated 2.3 million. The cause is unknown and although factors that may increase risk have been identified, attempts to curb disease progression have so far met with failure. However, we are at a turning point in scientific advancement with the emergence of promising new therapies that could help us shift the odds in our favor against this devastating disease.

Related episodes

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

We are pleased to be joined by Dorothy Achu, Regional Malaria Adviser, WHO African Region; Aimable Mbituyumuremyi, Director, National Malaria Control Program, Ministry of Health, Rwanda; Adam Aspinall, Senior Director, Access and Product Management, and George Jagoe, Executive Vice-President Medicines for Malaria Venture. To learn about antimalarial drug resistance in Africa to ensure patients can continue to be saved.

Dr Kerstin Kleinschmidt-Doerr | Could R399E Become a Promising Treatment for Restoring Joints and Relieving Pain in Osteoarthritis?

Dr Kerstin Kleinschmidt-Doerr | Could R399E Become a Promising Treatment for Restoring Joints and Relieving Pain in Osteoarthritis?

Osteoarthritis is a painful and progressive joint disorder that affects hundreds of millions of people worldwide. Typically, the options for treating the condition involve exercise or medication to reduce pain. However, these methods do not target the underlying structural problems in the joints of patients. Recently, researchers have uncovered a genetic susceptibility to osteoarthritis associated with a protein called GDF5, which is involved in skeletal growth and development. Alongside a team of scientists across Europe, Dr Kerstin Kleinschmidt-Doerr at Merck has explored a modified form of the GDF5 protein, named R399E, which showed effects in animal models and in-vitro experiments for treating pain and the underlying structural problems in osteoarthritis.

Dr Xiaomu Li | Understanding Diabetes: Revealing the Links Between High Blood Pressure and Insulin Resistance

Dr Xiaomu Li | Understanding Diabetes: Revealing the Links Between High Blood Pressure and Insulin Resistance

Cases of type 2 diabetes are on the rise around the world, so gaining a deeper understanding of this chronic condition is vital to ensure early diagnosis and good outcomes for patients. Dr Xiaomu Li and her colleagues at Zhongshan Hospital, Fudan University are conducting important research to understand the risk factors associated with developing type 2 diabetes. Their findings will help healthcare providers to identify patients at high risk of diabetes, enabling early diagnosis and targeted interventions to prevent the development of the condition.

Dr Millie Nakatsuka | Decoding Dizziness in the Emergency Room

Dr Millie Nakatsuka | Decoding Dizziness in the Emergency Room

Acute vestibular syndrome is one of the most common reasons people present at hospital with dizziness. The symptoms can arise from damage within the brain or the ear, and specialist medical knowledge or equipment is typically needed to determine the specific cause. Dr Nakatsuka from the University of Sydney in Australia has conducted a large-scale analysis and review of the published literature to determine whether well-trained emergency physicians can differentiate between the two causes, using a quick bedside physical examination without expensive special equipment.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.